Proteasome and cereblon — Drug Target

All drugs that target Proteasome and cereblon — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Proteasome inhibitor and immunomodulatory agent

Marketed (1)

• Ixazomib plus low-dose lenalidomide · Second Affiliated Hospital, School of Medicine, Zhejiang University · Proteasome inhibitor and immunomodulatory agent